Identification of Lactate as a Cardiac Protectant by Inhibiting Inflammation and Cardiac Hypertrophy Using a Zebrafish Acute Heart Failure Model
Acute heart failure (AHF) commonly arises from decompensated chronic heart failure or sudden structural and functional breakdown causing a decrease in cardiac contractility and consequently fluid accumulation and systemic congestion. Current treatment for AHF aims at reducing fluid overload and impr...
Main Authors: | Elijah R. Haege, Hui-Chi Huang, Cheng-chen Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/3/261 |
Similar Items
-
Zebrafish Heart Failure Models
by: Suneeta Narumanchi, et al.
Published: (2021-05-01) -
Cardiac‐specific ablation of glutaredoxin 3 leads to cardiac hypertrophy and heart failure
by: Jimmonique Donelson, et al.
Published: (2019-04-01) -
Role of microRNAs in cardiac hypertrophy, myocardial fibrosis and heart failure
by: De-li Dong, et al.
Published: (2011-06-01) -
Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
by: Ming-Yun Ho, et al.
Published: (2021-08-01) -
TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation
by: Andrea Grund, et al.
Published: (2019-10-01)